AAAAAA
Results:
1-10
|
Results: 10
Authors:
Eisen, HJ
Hobbs, RE
Davis, SF
Carrier, M
Mancini, DM
Smith, A
Valantine, I
Ventura, H
Mehra, M
Vachiery, JL
Rayburn, BK
Canver, CC
Laufer, G
Costanzo, MR
Copeland, J
Dureau, G
Frazier, OH
Dorent, R
Hauptman, PJ
Kells, C
Masters, R
Michaud, JL
Paradis, I
Renlund, DG
Vanhaecke, J
Mellein, B
Mueller, EA
Citation: Hj. Eisen et al., Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine: Results at 24 months after transplantation, TRANSPLANT, 71(1), 2001, pp. 70-78
Authors:
Kfoury, AG
Taylor, DO
Renlund, DG
Citation: Ag. Kfoury et al., Cardiac transplantation, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 474-481
Authors:
Taylor, DO
Yowell, RL
Kfoury, AG
Hammond, EH
Renlund, DG
Citation: Do. Taylor et al., Allograft coronary artery disease: Clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection, J HEART LUN, 19(6), 2000, pp. 518-521
Authors:
Taylor, DO
Farhoud, HH
Kfoury, AG
Pham, SM
Pigula, FA
Kormos, RL
Renlund, DG
Citation: Do. Taylor et al., Cardiac transplantation in survivors of lymphoma - A multi-institutional survey, TRANSPLANT, 69(10), 2000, pp. 2112-2115
Authors:
Taylor, DO
Barr, ML
Radovancevic, B
Renlund, DG
Mentzer, RM
Smart, FW
Tolman, DE
Frazier, OH
Young, JB
VanVeldhuisen, P
Citation: Do. Taylor et al., A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus, J HEART LUN, 18(4), 1999, pp. 336-345
Authors:
Stringham, JC
Bull, DA
Fuller, TC
Kfoury, AG
Taylor, DO
Renlund, DG
Karwande, SV
Citation: Jc. Stringham et al., Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization, J HEART LUN, 18(2), 1999, pp. 160-165
Authors:
Renlund, DG
Taylor, DO
Kfoury, AG
Shaddy, RS
Citation: Dg. Renlund et al., New UNOS rules: Historical background and implications for transplantationmanagement, J HEART LUN, 18(11), 1999, pp. 1065-1070
Authors:
Taylor, DO
Sharma, RC
Kfoury, AG
Renlund, DG
Citation: Do. Taylor et al., Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine, CLIN TRANSP, 13(4), 1999, pp. 296-299
Authors:
Eisen, HJ
Hobbs, RE
Davis, SF
Laufer, G
Mancini, DM
Renlund, DG
Valantine, H
Ventura, H
Vachiery, JL
Bourge, RC
Canver, CC
Carrier, M
Costanzo, MR
Copeland, J
Dureau, G
Frazier, OH
Dorent, R
Hauptman, PJ
Kells, C
Masters, R
Michaud, JL
Paradis, I
Smith, A
Vanhaecke, J
Feutren, G
Turkin, D
Mellein, B
Mueller, EA
Citation: Hj. Eisen et al., Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation, TRANSPLANT, 68(5), 1999, pp. 663-671
Authors:
Valantine, HA
Gao, SZ
Menon, SG
Renlund, DG
Hunt, SA
Oyer, P
Stinson, EB
Brown, BW
Merigan, TC
Schroeder, JS
Citation: Ha. Valantine et al., Impact of prophylactic immediate posttransplant ganciclovir on developmentof transplant atherosclerosis - A post hoc analysis of a randomized, placebo-controlled study, CIRCULATION, 100(1), 1999, pp. 61-66
Risultati:
1-10
|